New multifactorial antihypertensive drugs and cardiovascular risk factors: 6 June 1991, Milan, Italy, 20 August 1991, Amsterdam, The Netherlands
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
London [u.a.]
Acad. Press
1992
|
| Schriftenreihe: | European heart journal
Supplement ; 13A |
| Schlagworte: | |
| Beschreibung: | V, 69 S. Ill., zahlr. graph. Darst. |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV005432725 | ||
| 003 | DE-604 | ||
| 005 | 20161011 | ||
| 007 | t | ||
| 008 | 920713s1992 ad|| |||| 10||| eng d | ||
| 035 | |a (OCoLC)26757385 | ||
| 035 | |a (DE-599)BVBBV005432725 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-19 |a DE-12 |a DE-355 |a DE-29 | ||
| 050 | 0 | |a RC685.H8 | |
| 245 | 1 | 0 | |a New multifactorial antihypertensive drugs and cardiovascular risk factors |b 6 June 1991, Milan, Italy, 20 August 1991, Amsterdam, The Netherlands |c ed. by P. A. van Zwieten ... |
| 264 | 1 | |a London [u.a.] |b Acad. Press |c 1992 | |
| 300 | |a V, 69 S. |b Ill., zahlr. graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a European heart journal : Supplement |v 13A | |
| 650 | 4 | |a Antihypertensive Agents |v Congresses | |
| 650 | 4 | |a Antihypertensive Agents |x adverse effects |v Congresses | |
| 650 | 4 | |a Hypotensive agents |v Congresses | |
| 650 | 4 | |a Hypotensive agents |x Complications |v Congresses | |
| 650 | 4 | |a Risk Factors |v Congresses | |
| 650 | 0 | 7 | |a Lipidstoffwechsel |0 (DE-588)4035875-6 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Antihypertonikum |0 (DE-588)4002286-9 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Risikofaktor |0 (DE-588)4050131-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Urapidil |0 (DE-588)4136520-3 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Hypertonie |0 (DE-588)4026372-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Glucosestoffwechsel |0 (DE-588)4129732-5 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 1991 |z Amsterdam |2 gnd-content | |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 1991 |z Mailand |2 gnd-content | |
| 689 | 0 | 0 | |a Antihypertonikum |0 (DE-588)4002286-9 |D s |
| 689 | 0 | 1 | |a Risikofaktor |0 (DE-588)4050131-0 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Hypertonie |0 (DE-588)4026372-1 |D s |
| 689 | 1 | 1 | |a Urapidil |0 (DE-588)4136520-3 |D s |
| 689 | 1 | |5 DE-604 | |
| 689 | 2 | 0 | |a Urapidil |0 (DE-588)4136520-3 |D s |
| 689 | 2 | 1 | |a Glucosestoffwechsel |0 (DE-588)4129732-5 |D s |
| 689 | 2 | |5 DE-604 | |
| 689 | 3 | 0 | |a Urapidil |0 (DE-588)4136520-3 |D s |
| 689 | 3 | 1 | |a Lipidstoffwechsel |0 (DE-588)4035875-6 |D s |
| 689 | 3 | |5 DE-604 | |
| 689 | 4 | 0 | |a Antihypertonikum |0 (DE-588)4002286-9 |D s |
| 689 | 4 | |5 DE-604 | |
| 700 | 1 | |a Zwieten, Pieter A. van |d 1937-2014 |e Sonstige |0 (DE-588)172475686 |4 oth | |
| 830 | 0 | |a European heart journal |v Supplement ; 13A |w (DE-604)BV000900709 |9 13A | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-003397266 | ||
Datensatz im Suchindex
| _version_ | 1804119641157533696 |
|---|---|
| any_adam_object | |
| author_GND | (DE-588)172475686 |
| building | Verbundindex |
| bvnumber | BV005432725 |
| callnumber-first | R - Medicine |
| callnumber-label | RC685 |
| callnumber-raw | RC685.H8 |
| callnumber-search | RC685.H8 |
| callnumber-sort | RC 3685 H8 |
| callnumber-subject | RC - Internal Medicine |
| ctrlnum | (OCoLC)26757385 (DE-599)BVBBV005432725 |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02425nam a2200601 cb4500</leader><controlfield tag="001">BV005432725</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20161011 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">920713s1992 ad|| |||| 10||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)26757385</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV005432725</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield><subfield code="a">DE-12</subfield><subfield code="a">DE-355</subfield><subfield code="a">DE-29</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC685.H8</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">New multifactorial antihypertensive drugs and cardiovascular risk factors</subfield><subfield code="b">6 June 1991, Milan, Italy, 20 August 1991, Amsterdam, The Netherlands</subfield><subfield code="c">ed. by P. A. van Zwieten ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">London [u.a.]</subfield><subfield code="b">Acad. Press</subfield><subfield code="c">1992</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">V, 69 S.</subfield><subfield code="b">Ill., zahlr. graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">European heart journal : Supplement</subfield><subfield code="v">13A</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antihypertensive Agents</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antihypertensive Agents</subfield><subfield code="x">adverse effects</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Hypotensive agents</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Hypotensive agents</subfield><subfield code="x">Complications</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Risk Factors</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Lipidstoffwechsel</subfield><subfield code="0">(DE-588)4035875-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Antihypertonikum</subfield><subfield code="0">(DE-588)4002286-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Risikofaktor</subfield><subfield code="0">(DE-588)4050131-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Urapidil</subfield><subfield code="0">(DE-588)4136520-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Hypertonie</subfield><subfield code="0">(DE-588)4026372-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Glucosestoffwechsel</subfield><subfield code="0">(DE-588)4129732-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1991</subfield><subfield code="z">Amsterdam</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1991</subfield><subfield code="z">Mailand</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Antihypertonikum</subfield><subfield code="0">(DE-588)4002286-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Risikofaktor</subfield><subfield code="0">(DE-588)4050131-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Hypertonie</subfield><subfield code="0">(DE-588)4026372-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Urapidil</subfield><subfield code="0">(DE-588)4136520-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">Urapidil</subfield><subfield code="0">(DE-588)4136520-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="1"><subfield code="a">Glucosestoffwechsel</subfield><subfield code="0">(DE-588)4129732-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="3" ind2="0"><subfield code="a">Urapidil</subfield><subfield code="0">(DE-588)4136520-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2="1"><subfield code="a">Lipidstoffwechsel</subfield><subfield code="0">(DE-588)4035875-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="4" ind2="0"><subfield code="a">Antihypertonikum</subfield><subfield code="0">(DE-588)4002286-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="4" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zwieten, Pieter A. van</subfield><subfield code="d">1937-2014</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)172475686</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">European heart journal</subfield><subfield code="v">Supplement ; 13A</subfield><subfield code="w">(DE-604)BV000900709</subfield><subfield code="9">13A</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-003397266</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift 1991 Amsterdam gnd-content (DE-588)1071861417 Konferenzschrift 1991 Mailand gnd-content |
| genre_facet | Konferenzschrift 1991 Amsterdam Konferenzschrift 1991 Mailand |
| id | DE-604.BV005432725 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T16:29:25Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-003397266 |
| oclc_num | 26757385 |
| open_access_boolean | |
| owner | DE-19 DE-BY-UBM DE-12 DE-355 DE-BY-UBR DE-29 |
| owner_facet | DE-19 DE-BY-UBM DE-12 DE-355 DE-BY-UBR DE-29 |
| physical | V, 69 S. Ill., zahlr. graph. Darst. |
| publishDate | 1992 |
| publishDateSearch | 1992 |
| publishDateSort | 1992 |
| publisher | Acad. Press |
| record_format | marc |
| series | European heart journal |
| series2 | European heart journal : Supplement |
| spelling | New multifactorial antihypertensive drugs and cardiovascular risk factors 6 June 1991, Milan, Italy, 20 August 1991, Amsterdam, The Netherlands ed. by P. A. van Zwieten ... London [u.a.] Acad. Press 1992 V, 69 S. Ill., zahlr. graph. Darst. txt rdacontent n rdamedia nc rdacarrier European heart journal : Supplement 13A Antihypertensive Agents Congresses Antihypertensive Agents adverse effects Congresses Hypotensive agents Congresses Hypotensive agents Complications Congresses Risk Factors Congresses Lipidstoffwechsel (DE-588)4035875-6 gnd rswk-swf Antihypertonikum (DE-588)4002286-9 gnd rswk-swf Risikofaktor (DE-588)4050131-0 gnd rswk-swf Urapidil (DE-588)4136520-3 gnd rswk-swf Hypertonie (DE-588)4026372-1 gnd rswk-swf Glucosestoffwechsel (DE-588)4129732-5 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 1991 Amsterdam gnd-content (DE-588)1071861417 Konferenzschrift 1991 Mailand gnd-content Antihypertonikum (DE-588)4002286-9 s Risikofaktor (DE-588)4050131-0 s DE-604 Hypertonie (DE-588)4026372-1 s Urapidil (DE-588)4136520-3 s Glucosestoffwechsel (DE-588)4129732-5 s Lipidstoffwechsel (DE-588)4035875-6 s Zwieten, Pieter A. van 1937-2014 Sonstige (DE-588)172475686 oth European heart journal Supplement ; 13A (DE-604)BV000900709 13A |
| spellingShingle | New multifactorial antihypertensive drugs and cardiovascular risk factors 6 June 1991, Milan, Italy, 20 August 1991, Amsterdam, The Netherlands European heart journal Antihypertensive Agents Congresses Antihypertensive Agents adverse effects Congresses Hypotensive agents Congresses Hypotensive agents Complications Congresses Risk Factors Congresses Lipidstoffwechsel (DE-588)4035875-6 gnd Antihypertonikum (DE-588)4002286-9 gnd Risikofaktor (DE-588)4050131-0 gnd Urapidil (DE-588)4136520-3 gnd Hypertonie (DE-588)4026372-1 gnd Glucosestoffwechsel (DE-588)4129732-5 gnd |
| subject_GND | (DE-588)4035875-6 (DE-588)4002286-9 (DE-588)4050131-0 (DE-588)4136520-3 (DE-588)4026372-1 (DE-588)4129732-5 (DE-588)1071861417 |
| title | New multifactorial antihypertensive drugs and cardiovascular risk factors 6 June 1991, Milan, Italy, 20 August 1991, Amsterdam, The Netherlands |
| title_auth | New multifactorial antihypertensive drugs and cardiovascular risk factors 6 June 1991, Milan, Italy, 20 August 1991, Amsterdam, The Netherlands |
| title_exact_search | New multifactorial antihypertensive drugs and cardiovascular risk factors 6 June 1991, Milan, Italy, 20 August 1991, Amsterdam, The Netherlands |
| title_full | New multifactorial antihypertensive drugs and cardiovascular risk factors 6 June 1991, Milan, Italy, 20 August 1991, Amsterdam, The Netherlands ed. by P. A. van Zwieten ... |
| title_fullStr | New multifactorial antihypertensive drugs and cardiovascular risk factors 6 June 1991, Milan, Italy, 20 August 1991, Amsterdam, The Netherlands ed. by P. A. van Zwieten ... |
| title_full_unstemmed | New multifactorial antihypertensive drugs and cardiovascular risk factors 6 June 1991, Milan, Italy, 20 August 1991, Amsterdam, The Netherlands ed. by P. A. van Zwieten ... |
| title_short | New multifactorial antihypertensive drugs and cardiovascular risk factors |
| title_sort | new multifactorial antihypertensive drugs and cardiovascular risk factors 6 june 1991 milan italy 20 august 1991 amsterdam the netherlands |
| title_sub | 6 June 1991, Milan, Italy, 20 August 1991, Amsterdam, The Netherlands |
| topic | Antihypertensive Agents Congresses Antihypertensive Agents adverse effects Congresses Hypotensive agents Congresses Hypotensive agents Complications Congresses Risk Factors Congresses Lipidstoffwechsel (DE-588)4035875-6 gnd Antihypertonikum (DE-588)4002286-9 gnd Risikofaktor (DE-588)4050131-0 gnd Urapidil (DE-588)4136520-3 gnd Hypertonie (DE-588)4026372-1 gnd Glucosestoffwechsel (DE-588)4129732-5 gnd |
| topic_facet | Antihypertensive Agents Congresses Antihypertensive Agents adverse effects Congresses Hypotensive agents Congresses Hypotensive agents Complications Congresses Risk Factors Congresses Lipidstoffwechsel Antihypertonikum Risikofaktor Urapidil Hypertonie Glucosestoffwechsel Konferenzschrift 1991 Amsterdam Konferenzschrift 1991 Mailand |
| volume_link | (DE-604)BV000900709 |
| work_keys_str_mv | AT zwietenpieteravan newmultifactorialantihypertensivedrugsandcardiovascularriskfactors6june1991milanitaly20august1991amsterdamthenetherlands |